Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-02-14 1:37 pm Purchase | 13G | Annexon Inc. ANNX | FEDERATED HERMES INC. FHI | 2,025,600 5.28% | 2,025,600 (New Position) | View |
2022-02-14 1:35 pm Purchase | 13G | Akouos Inc. AKUS | FEDERATED HERMES INC. FHI | 2,498,442 7.24% | 178,960 (+7.72%) | View |
2022-02-14 1:34 pm Purchase | 13G | ANAPTYSBIO INC ANAB | FEDERATED HERMES INC. FHI | 1,604,287 5.8% | 330,520 (+25.95%) | View |
2022-02-14 1:31 pm Purchase | 13G | Alector Inc. ALEC | FEDERATED HERMES INC. FHI | 5,280,847 6.5% | 998,284 (+23.31%) | View |
2022-02-14 1:29 pm Sale | 13G | Amphastar Pharmaceuticals Inc. AMPH | FEDERATED HERMES INC. FHI | 3,464,335 7.24% | -6,685,665 (-65.87%) | View |
2022-02-14 1:26 pm Purchase | 13G | Orchard Therapeutics plc ORTX | FEDERATED HERMES INC. FHI | 8,309,859 6.62% | 8,309,859 (New Position) | View |
2022-02-14 1:26 pm Unchanged | 13G | ATYR PHARMA INC LIFE | FEDERATED HERMES INC. FHI | 5,222,250 18.79% | 0 (Unchanged) | View |
2022-02-14 1:24 pm Purchase | 13G | Omega Alpha SPAC OMEG | FEDERATED HERMES INC. FHI | 1,000,000 6.99% | 1,000,000 (New Position) | View |
2022-02-14 1:23 pm Unchanged | 13G | BCLS Acquisition Corp. BLSA | FEDERATED HERMES INC. FHI | 1,000,000 6.73% | 0 (Unchanged) | View |
2022-02-14 1:21 pm Purchase | 13G | CASI PHARMACEUTICALS HLDGS INC CASI | FEDERATED HERMES INC. FHI | 10,150,000 7.26% | 3,150,000 (+45.00%) | View |
2022-02-14 1:19 pm Purchase | 13G | CONTRAFECT Corp CFRX | FEDERATED HERMES INC. FHI | 7,297,188 18.55% | 2,000,000 (+37.76%) | View |
2022-02-14 1:19 pm Purchase | 13G | Braze Inc. BRZE | FEDERATED HERMES INC. FHI | 530,000 5.33% | 530,000 (New Position) | View |
2022-02-14 1:17 pm Purchase | 13G | DYNAVAX TECHNOLOGIES CORP COM DVAX | FEDERATED HERMES INC. FHI | 16,782,838 13.92% | 4,261,038 (+34.03%) | View |
2022-02-14 1:16 pm Purchase | 13G | AVROBIO Inc. AVRO | FEDERATED HERMES INC. FHI | 2,595,453 5.95% | 2,595,453 (New Position) | View |
2022-02-14 1:14 pm Sale | 13G | Korro Bio Inc. KRRO | FEDERATED HERMES INC. FHI | 2,801,066 8.1% | -800,206 (-22.22%) | View |
2022-02-14 1:12 pm Purchase | 13G | Avidity Biosciences Inc. RNA | FEDERATED HERMES INC. FHI | 2,474,500 5.28% | 2,474,500 (New Position) | View |
2022-02-14 1:12 pm Sale | 13G | GAMIDA CELL LTD GMDAQ | FEDERATED HERMES INC. FHI | 4,363,315 7.36% | -689,208 (-13.64%) | View |
2022-02-14 1:09 pm Purchase | 13G | Aris Water Solutions Inc. ARIS | FEDERATED HERMES INC. FHI | 1,250,000 6.16% | 1,250,000 (New Position) | View |
2022-02-14 1:09 pm Purchase | 13G | Merus N.V. MRUS | FEDERATED HERMES INC. FHI | 3,679,300 8.51% | 742,502 (+25.28%) | View |
2022-02-14 1:07 pm Purchase | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | FEDERATED HERMES INC. FHI | 3,694,929 14.02% | 242,119 (+7.01%) | View |